Back to
FIRST MANHATTAN CO. LLC.
ARWR
Showing 0 of 22 quarters
Position history for
FIRST MANHATTAN CO. LLC.'s holdings in ARROWHEAD PHARMACEUTICALS IN
No. First Manhattan exited its ARWR (Arrowhead Pharmaceuticals in) position in Q1 2024. Its Q4 2023 13F listed 743,721 shares worth $22.8M. First Manhattan already held ARWR in its Q4 2018 13F, the earliest on record, and held it in 21 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.